Further evidence rofecoxib increases MI risk in elderly

Author：  

Publisher： Adis International

ISSN： 0114-9954

Source： Reactions Weekly, Vol.1, Iss.1038, 2005-01, pp. : 5-5

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Rofecoxib [Vioxx] appears to increase the risk of myocardial infarction (MI) and sudden cardiac death (SCD) compared with celecoxib

By  

Reactions Weekly, Vol. 1, Iss. 1020, 2004-01 ,pp. : 4-4

Adis International

Access to resources Recommend Favorite

Rofecoxib [Vioxx] appears to increase the risk of myocardial infarction (MI) and sudden cardiac death (SCD) compared with celecoxib

By  

Inpharma, Vol. 1, Iss. 1456, 2004-01 ,pp. : 21-21

Adis International

Access to resources Recommend Favorite

Inappropriate drug use increases risk of hospitalisation in the elderly

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 604, 2010-01 ,pp. : 4-4

Adis International

Access to resources Recommend Favorite

Is acute rofecoxib use associated with acute MI?

By  

Reactions Weekly, Vol. 1, Iss. 1101, 2006-01 ,pp. : 3-3

Adis International

Access to resources Recommend Favorite

Celecoxib and rofecoxib: risk of GI bleeding

By  

Inpharma, Vol. 1, Iss. 1318, 2001-01 ,pp. : 21-21

Adis International

Access to resources Recommend Favorite